Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea
试验速览
- 阶段
- 不适用
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- prevalence of metabolic syndrome (MetS)
研究概览
简要总结
The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia.
Primary objective:
• To investigate the prevalence of the MetS in Korean patients with schizophrenia
Secondary objectives:
• To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of schizophrenia according to DSM-IV-TR
- •Age between 18-65 years
排除标准
- 未提供
结局指标
主要结局
prevalence of metabolic syndrome (MetS)
MetS will be diagnosed according to NCEP ATP III with the Asian-Pacific abdominal obesity criterion (≥90 cm in men, ≥85 cm in women) 3 or more of the following criteria 1. fasting plasma glucose \>= 100 mg/dl or drug use to treat elevated glucose 2. serum triglyceride (TG) \>= 150 mg/dl or drug use to treat elevated TG 3. HDL cholesterol level \< 40mg /dl in males, \< 50 mg/dl in female or drug use to treat low HDL 4. Systolic BP \>=130 mmHg, diastolic BP \>=85 or drug use to treat hypertension 5. Abdominal obesity : above described
次要结局
未报告次要终点
研究者
Yeon-Ho Joo
Professor
Asan Medical Center